Test Module 2

How have country-based malaria experts adapted to the double challenge of malaria and COVID-19? What successes have they achieved, and where are the remaining gaps?  In a virtual forum on 3 September, 10 Ministry of Health representatives shared their experiences and reflections; you can watch their presentations below.

On 4 September, participants heard from senior political and health leaders from 2 regions that are heavily impacted by malaria; you will find below the presentations of WH

Roles: Everyone: All Users

Topics: Coronavirus (COVID-19), Global Health

• Nine CEPI-supported candidate vaccines are part of the COVAX initiative, with a further nine candidates under evaluation, and procurement conversations on-going with additional producers not currently receiving research and development (R&D) funding through COVAX – giving COVAX the largest and most diverse COVID-19 vaccine portfolio in the world
  
• 80 potentially self-financing countries have submitted non-binding expressions of interest to the Gavi-coor

  Roles: Everyone: All Users

  Regions: Afghanistan, Argentina, Canada , Chile, China, France , Ireland , Norway , Tonga , United Kingdom , United States , West Bank , Zambia

  Topics: Coronavirus (COVID-19), Economic Prosperity and Trade Policy, Energy, Global Health, Refugee and Humanitarian Assistance, Science, Technology, and Innovation

• Yellow fever – Republic of South Sudan

  Roles: Everyone: All Users

  Regions: Sudan , Uganda

  Topics: Global Health, Global Women's Issues

• Yellow fever – Uganda

  Roles: Everyone: All Users

  Topics: Global Health